1
|
Mughal EU, Amjid S, Sadiq A, Naeem N, Nazir Y, Alrafai HA, Hassan AA, Al-Nami SY, Abdel Hafez AA, Ali Shah SW, Ghias M. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship, in vitro, QSAR, molecular docking, MD simulations and drug-likeness studies. J Biomol Struct Dyn 2024; 42:244-260. [PMID: 37096830 DOI: 10.1080/07391102.2023.2198609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Accepted: 03/10/2023] [Indexed: 04/26/2023]
Abstract
In the present study, a series of 2-amino-4,6-diarylpyrimidine derivatives was designed, synthesized, characterized and evaluated for their in vitro α-glucosidase and α-amylase enzyme inhibition assays. The outcomes proved that this class of compounds exhibit considerable inhibitory activity against both enzymes. Among the target compounds, compounds 4p and 6p demonstrated the most potent dual inhibition with IC50 = 0.087 ± 0.01 μM for α-glucosidase; 0.189 ± 0.02 μM for α-amylase and IC50 = 0.095 ± 0.03 μM for α-glucosidase; 0.214 ± 0.03 μM for α-amylase, respectively as compared to the standard rutin (IC50 = 0.192 ± 0.02 μM for α-glucosidase and 0.224 ± 0.02 μM for α-amylase). Remarkably, the enzyme inhibition results indicate that test compounds have stronger inhibitory effect on the target enzymes than the positive control, with a significantly lower IC50 value. Moreover, these series of compounds were found to inhibit α-glucosidase activity in a reversible mixed-type manner with IC50 between 0.087 ± 0.01 μM to 1.952 ± 0.26 μM. Furthermore, molecular docking studies were performed to affirm the binding interactions of this scaffold to the active sites of α-glucosidase and α-amylase enzymes. The quantitative structure-activity relationship (QSAR) investigations showed a strong association between 1p-15p structures and their inhibitory actions (IC50) with a correlation value (R2) of 0.999916. Finally, molecular dynamic (MD) simulations were carried out to assess the dynamic behavior, stability of the protein-ligand complex, and binding affinity of the most active inhibitor 4p. The experimental and theoretical results therefore exposed a very good compatibility. Additionally, the drug-likeness assay revealed that some compounds exhibit a linear association with Lipinski's rule of five, indicating good drug-likeness and bioactivity scores for pharmacological targets.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
| | - Samreen Amjid
- Department of Chemistry, University of Gujrat, Gujrat, Pakistan
| | - Amina Sadiq
- Department of Chemistry, Govt. College Women University, Sialkot, Pakistan
| | - Nafeesa Naeem
- Department of Chemistry, University of Gujrat, Gujrat, Pakistan
| | - Yasir Nazir
- Department of Chemistry, Allama Iqbal Open University, Islamabad, Pakistan
| | - H A Alrafai
- Department of Chemistry, Faculty of Science, King Khalid University, Abraham, Saudi Arabia
| | - Abeer A Hassan
- Department of Chemistry, Faculty of Science, King Khalid University, Abraham, Saudi Arabia
| | - Samar Y Al-Nami
- Department of Chemistry, Faculty of Science, King Khalid University, Abraham, Saudi Arabia
| | - Amal A Abdel Hafez
- Department of Chemistry, Faculty of Science, King Khalid University, Abraham, Saudi Arabia
| | - Syed Wadood Ali Shah
- Department of Pharmacy, University of Malakand, Chakdara Dir, Khyber Pakhtunkhwa, Pakistan
| | - Mehreen Ghias
- Department of Pharmacy, University of Malakand, Chakdara Dir, Khyber Pakhtunkhwa, Pakistan
| |
Collapse
|